Consortium for Advanced Research Training in Africa Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT01614249
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Consortium for Advanced Research Training in Africa (CARTA)

Active Ingredients

Drugs in Phase 3 Trials (2)

fish oil (Omegavan) (1 trial)

soybean oil (Intralipid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2